Retinal gene therapy for X-linked retinoschisis showed that AAV8 treatment had positive safety and tolerability outcomes

Researchers at the NIH, National Eye Institute, Bethesda have reported a phase I/IIa study on the use of an AAV8 vector for ocular gene delivery for the treatment of X-linked juvenile retinoschisis (XLRS).  While the small 9-patient study was focused on safety and tolerability, one participant in the trial provided the first signal of possible efficacy.  The positive data reported suggest that promising findings will be used to build “additional dose levels and strategies for immune suppression to control inflammatory sequela elicited by the vector”.  Nine participants were designed as a pilot safety trial, treated study eyes were neither masked nor randomized and only one eye was dosed per participant.

 

X-linked retinoschisis (XLRS) is a monogenic X-linked disease that leads to schisis (or splitting) of the neural retina leading to reduced visual acuity in approximately 12,000 males in the US.  The disorder affects visual acuity from an early age, typically with visual limitations in their daily function, including difficulty with reading, and obtaining a driver’s license.  According to the researchers, XLRS manifests haplosufficiency as female carriers have no evidence of the disease and demonstrate preservation of visual function and retinal structure across their lifespan.  As a consequence, using gene transfer as a therapeutic intervention may be capable to partially restore XLRS gene therapy.

 

The XLRS disease is caused by mutations in the RS1 gene coded by the retinoschisin protein secreted principally in the outer retina. This phase I/IIa single-center, prospective, open-label, three-dose-escalation clinical trial administered vector to nine participants with pathogenic RS1 mutations. The eye of each participant with worse acuity (≤63 letters; Snellen 20/63) received the AAV8-RS1 gene vector by intravitreal injection. Three participants were assigned to each of three dosage groups: 1e9 (1X10^9) vector genomes (vg)/eye, 1e10 (1X10^10)  vg/eye, and 1e11 (1X10^11) vg/eye. According to the researchers, the investigational product was generally well tolerated in all but one individual. Ocular events included dose-related inflammation that resolved with topical and oral corticosteroids. Systemic antibodies against AAV8 increased in a dose-related fashion, but no antibodies against RS1 were observed. Commenting in the paper, the research stated that the phase I/IIa dose-escalation trial of AAV8-RS1retinal gene transfer by intravitreal injection “is the first clinical study to explore treating a monogenic retinal degeneration by intravitreal application of an AAV8 vector serotype. The outcome measures focused on safety parameters and assessed the evidence of biologic activity”.

48 thoughts on “Retinal gene therapy for X-linked retinoschisis showed that AAV8 treatment had positive safety and tolerability outcomes”

  1. Hello there I am so thrilled I found your website, I really found you by error, while I was browsing on Askjeeve for something else,
    Anyways I am here now and would just like to say
    kudos for a tremendous post and a all round enjoyable
    blog (I also love the theme/design), I don’t have time to read it all at the moment but I have book-marked
    it and also added your RSS feeds, so when I have time I will be back to read much more,
    Please do keep up the superb b.

  2. Hello! I know this is kinda off topic however , I’d figured I’d ask.
    Would you be interested in exchanging links or maybe guest writing
    a blog post or vice-versa? My blog addresses a lot of the same subjects as
    yours and I feel we could greatly benefit from each other.
    If you happen to be interested feel free to
    send me an e-mail. I look forward to hearing from you!
    Terrific blog by the way!

  3. I do not know if it’s just me or if everybody else experiencing problems with your
    website. It seems like some of the written text in your posts are
    running off the screen. Can someone else please comment and let me
    know if this is happening to them as well? This could be a issue with my web browser because I’ve had this
    happen before. Kudos

  4. I just want to tell you that I am all new to blogging and actually liked you’re blog site. Likely I’m likely to bookmark your blog . You surely come with perfect posts. Many thanks for revealing your web page.

  5. I simply want to mention I am just beginner to blogging and site-building and seriously savored you’re website. Likely I’m likely to bookmark your blog post . You absolutely have impressive stories. With thanks for sharing your website page.

  6. The new Zune browser is surprisingly good, but not as good as the iPod’s. It works well, but isn’t as fast as Safari, and has a clunkier interface. If you occasionally plan on using the web browser that’s not an issue, but if you’re planning to browse the web alot from your PMP then the iPod’s larger screen and better browser may be important.

  7. Hi there! Someone in my Myspace group shared this site with us so I came to give it a look. I’m definitely loving the information. I’m bookmarking and will be tweeting this to my followers! Outstanding blog and wonderful style and design.

  8. Hi just wanted to give you a brief heads up and let you know a few of the pictures aren’t loading properly. I’m not sure why but I think its a linking issue. I’ve tried it in two different browsers and both show the same outcome.

  9. Hello there! I just would love to offer a significant thumbs up for the fantastic information you have here on this blog post. I will be coming back to your blog for even more quickly.

Leave a Reply

Your email address will not be published.